Start an analysis for MXCT
MaxCyte, Inc.
Stock · NASDAQProgram summary
| Field | Value | As of | Source |
|---|---|---|---|
| Current authorization | $10m | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Remaining authorization | $5m | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Program expiry | 05-May-27 | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Repurchased last quarter | $4m | 30-Sep-26 | 10-Q filed 10-Nov-26 |
| Has used an ASR | No | — |
Programs
| Authorized on | Authorized | Remaining | Expires | Terms |
|---|---|---|---|---|
| 12-May-26 | $10m | $5m | 05-May-27 | All shares were repurchased pursuant to a $10 million repurchase authorized by our Board and publicly announced on May 12, 2026.10-Q filed 10-Nov-26 |
Open-market repurchases
- Jul ’26
- Aug ’26
- Sep ’26
| Month ended | Shares | Avg price | ≈ Value | Source |
|---|---|---|---|---|
| 30-Sep-26 | 0 | — | $0 | 10-Q filed 10-Nov-26 |
| 31-Aug-26 | 0 | — | $0 | 10-Q filed 10-Nov-26 |
| 31-Jul-26 | 2,947,468 | $1.36 | $4m | 10-Q filed 10-Nov-26 |